SupplementDrug
Soy isoflavones clinical trials
Also written Novasoy.
- studies test it
- 41
- open now
- 1
- in phase 3
- 5
- first study started
- 1996
Keep track of what changes. Save the soy isoflavones studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Development codes
Other names
Combined with it in one product
Studies by the year they started
40 studies that test it; most in 2002 (4)
| Year | Studies |
|---|---|
| 1996 | 1 |
| 2000 | 1 |
| 2001 | 3 |
| 2002 | 4 |
| 2003 | 4 |
| 2004 | 4 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 9
- Phase 3
- 5
- Phase 4
- 3
- No phase
- 22
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 39
Wake Forest University Health Sciences (3) · National Nutrition and Food Technology Institute (2) · Northwestern University (2) · The Archer-Daniels-Midland Company (1) · Ohio State University Comprehensive Cancer Center (1) · University of Southern California (1) · Ahvaz Jundishapur University of Medical Sciences (1) · Ohio State University (1)
Often tested with
Tested in the same studies.
Whey Proteins (2) · Cisplatin (1) · Vitamin D (1) · Soybean Proteins (1) · Omega-3 fatty acid (1) · Cholecalciferol (1) · Lycopene (1) · Exercise Pain Management (1)
Studies
Open first, then newest update. How each study uses soy isoflavones is read from its arms, and is right about nine times in ten.
Testing it · 41
- Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) StudyRecruitingPhase 2Rajesh KumarNCT05667701Written as Soy isoflavone
- Evaluation of Soy Isoflavones on Skin Ageing ParametersCompletedNot applicableThe Archer-Daniels-Midland CompanyNCT06047145Written as soy isoflavones
- Phytoestrogens and Breast Cancer - Effects of Phytoestrogens on Markers of Disease Progression and Gene ExpressionWithdrawnNot applicableDanish Cancer SocietyNCT04880369Written as Soy isoflavones
- Soy Isoflavones in Treating Patients With Recurrent Prostate Cancer or Rising Prostate-Specific AntigenCompletedNot applicableOhio State University Comprehensive Cancer CenterNCT01682941Written as Arm I Soy Bread
- Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast CancerCompletedNot applicableUniversity of Southern CaliforniaNCT01219075Written as soy isoflavones
- The Effect of Soy Isoflavones on Non-alcoholic Fatty Liver Disease and the Level of FGF-21 and Fetuin ACompletedNot applicableAhvaz Jundishapur University of Medical SciencesNCT06101433Written as Soy isoflavone
- Dietary Soy Isoflavones In Chronic PancreatitisCompletedNot applicableOhio State UniversityNCT02577640Written as Soy bread
- Safety and Effectiveness of Soy Phytoestrogens to Prevent Bone LossCompletedNot applicableBaylor College of MedicineNCT00665860Written as Soy isoflavones
- COVID-19: Collecting Measurements of Renin-angiotensin-system Markers, Such as Angiotensin-2 and Angiotensin 1-7Status unknownNot applicableGuyguy K Tshima, MDNCT04537585Written as Tomeka®
- Isoflavones and Peritoneal DialysisCompletedNot applicableNational Nutrition and Food Technology InstituteNCT04185168Written as soy isoflavone
- Alzheimer's Disease: Potential Benefit of IsoflavonesCompletedPhase 2University of Wisconsin, MadisonNCT00205179Written as Novasoy
- Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and NeckCompletedPhase 1Emory UniversityNCT02075112Written as Soy isoflavone
- The Effects of Isoflavones on Cardiovascular and Bone Metabolism Markers in Peritoneal Dialysis PatientsStatus unknownNot applicableNational Nutrition and Food Technology InstituteNCT03773029Written as soy isoflavone
- Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate CancerCompletedPhase 2Wake Forest University Health SciencesNCT00499408Written as soy
- Soy and Lipoproteins in Postmenopausal WomenCompletedNot applicableJohns Hopkins UniversityNCT00201162Written as Soy
- Use of a Soy-based Meal Replacement Weight Loss Intervention to Impact Ectopic FatCompletedNot applicableWake Forest University Health SciencesNCT01298817Written as Medifast meal replacement products
- Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate CancerCompletedPhase 2Wake Forest University Health SciencesNCT00345813Written as soy isoflavones
- Using Soy Estrogens to Prevent Bone Loss and Other Menopausal SymptomsCompletedPhase 3University of MiamiNCT00076050Written as Soy isoflavones
- Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing SurgeryCompletedPhase 2National Cancer Institute (NCI)NCT02007200Written as Soy Isoflavones
- Evaluate the Effect of Omega-3 vs Soy Isoflavones in Postmenopausal Women With Moderate to Severe Vasomotor SymptomsCompletedPhase 4Instituto PalaciosNCT02195609Written as Soy Isoflavones
See all 41 studies that test soy isoflavones →
Given in every arm · 1 — soy isoflavones is usual care beside what is tested
As the comparator · 2 — what is tested is compared with soy isoflavones
- The Effect of 8-weeks of Bovine Colostrum and Soy Protein Supplementation in Rugby PlayersCompletedNot applicableUniversity of SaskatchewanNCT02951923Written as Soy
- Dairy Modulation of Oxidative and Inflammatory Stress in Overweight and Obese SubjectsCompletedNot applicableUniversity of TennesseeNCT00948038Written as Soy
Codes
What other systems call soy isoflavones · ClinicalTrials.gg INT015368
- UNII (FDA) 71B37NR06DSOY ISOFLAVONESOne source FDA
- NCI Thesaurus C65152Soy IsoflavonesOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 71B37NR06D | SOY ISOFLAVONES | One source FDA |
| NCI Thesaurus | C65152 | Soy Isoflavones | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.